Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Can hair loss be reversed with Oxy133, a sterol based drug candidate?
Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life...
Can we use our immune cells to fight lung disease?
Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...
What's Calcium's role in heart and kidney disease?
Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes...